Key Highlights

  • SCWorx (NASDAQ:WORX) changed hands at USD 1.74 on November 4, 2026, up 21.71% intraday, with 3.28 million shares traded per published market figures.
  • No company announcement dated November 2 to November 4, 2026 turned up, which points to a move driven by trading rather than a new filing or release.
  • Nasdaq's Hearings Panel signed off on continued listing on October 5, 2026; the one-year monitoring window runs to October 2, 2027, and shares resumed trading on October 7.
  • Unaudited Revenue for the first half of 2026 was roughly USD 1.45 million, with a net loss near USD 295,000, which confirms how small the operation is.

Price Action for SCWorx in the Session (up USD 0.31, 21.71%)

SCWorx (NASDAQ:WORX) was marked at USD 1.74 in regular hours on November 4, 2026, a 21.71% gain. Working from that, the prior close was about USD 1.43 (calculated), so the advance amounts to roughly USD 0.31 a share. Published data put Volume at 3.28 million shares and market Capitalization near USD 2.41 million; that capitalization figure does not square with company filings, so treat it cautiously. Checks of corporate statements, exchange bulletins and regulatory documents found nothing dated November 2 to November 4, 2026. The best label is trading-driven: the buying has no disclosed cause and may reflect short-term positioning rather than any change in the business.

Background: Listing Status and a Recent Raise

The most pertinent recent developments involve the listing. On June 23, 2026 the Nasdaq Hearings Panel permitted continued listing on conditions that included a Reverse Stock Split and a deadline for the bid price to recover. A partial compliance letter followed on July 29, 2026, noting the stock still had to close at a USD 1.00 minimum bid on 20 straight sessions. On October 5, 2026 the panel granted continued listing on the Nasdaq Capital Market with monitoring through October 2, 2027, and the company said trading would restart at the opening bell on October 7. Separately, an Equity Financing closed on September 17, 2026: 350,000 units sold at USD 2.68 for about USD 938,000 gross. The current quote sits beneath that unit price.

Business Developments and Risk Points

SCWorx supplies data management services to healthcare Supply chains. On October 19, 2026 it disclosed a deal with an independent, community-owned health system in the Southwest, and on August 6, 2026 it reported a two-year agreement with a Massachusetts integrated delivery network. Revenue for the first half of 2026 was unaudited at about USD 1.45 million, while the net result was a loss of about USD 295,000. Being a micro cap, the stock can swing on a handful of trades, bid-ask spreads may be wide, and quoted gains can evaporate fast. With the price near USD 1.74, not far above the USD 1.00 minimum bid, a slide could renew concerns over the listing. Equity raises also dilute current holders, since new shares divide the same Earnings among a larger count.

Where Things Stand

SCWorx (NASDAQ:WORX) is up 21.71% on November 4, 2026, and no company announcement from November 2 to November 4 could be found, so the advance seems trading-driven. The recent setting includes a Nasdaq ruling that permits continued listing under monitoring, a modest equity raise and a new customer contract, although the revenue base remains tiny. Gains in micro caps often reverse quickly, and nothing in this piece points to a continuation. This article is for information only and does not constitute Investment advice.